erdafitinib for fgfr-mutated urothelial carcinoma
Published 6 years ago • 1.9K plays • Length 4:43Download video MP4
Download video MP3
Similar videos
-
2:31
an update on erdafitinib for metastatic/uresectable fgfr alteration urothelial carcinoma
-
1:47
thor: erdafitinib in metastatic urothelial cancer with fgfr alterations
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
1:49
blc2001: erdafitinib for the treatment of metastatic urothelial carcinoma
-
1:04
thor: erdafitinib in advanced or metastatic urothelial cancer and fgfr alterations
-
1:47
the future role of erdafitinib in advanced urothelial carcinoma
-
2:20
erdafitinib /- cetrelimab in muc patients with fgfr alterations
-
2:12
erdafitinib: one more tool for bladder cancer
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
3:42
norse: erdafitinib cetrelimab in muc with fgfr alterations
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
2:53
effect of fgfr status on checkpoint inhibitor response in bladder cancer
-
2:15
tar-210 erdafitinib intravesical delivery system in non-muscle invasive bladder cancer
-
1:21
expansion cohort results of ragnar: erdafitinib in cca with fgfr alterations
-
0:55
targeted therapy option of erdafitinib in bladder cancer #oncology #cancer #2023
-
2:52
fgfri treatment-emergent aes in urothelial cancer
-
1:28
erdafitinib for bladder cancer: more to come following fda approval
-
5:14
erdafitinib demonstrates efficacy in intermediate-risk nmibc with fgfr alterations
-
1:17
recent advances in the treatment of upper tract urothelial carcinoma